Cargando…
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
BACKGROUND: Alzheimer’s disease (AD) is the most frequently diagnosed neurodegenerative disorder affecting humans, with advanced age being the most prominent risk factor for developing AD. Despite intense research efforts aimed at elucidating the precise molecular underpinnings of AD, a definitive a...
Autores principales: | Proctor, Carole J, Pienaar, Ilse Sanet, Elson, Joanna L, Kirkwood, Thomas BL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583291/ https://www.ncbi.nlm.nih.gov/pubmed/22748062 http://dx.doi.org/10.1186/1750-1326-7-32 |
Ejemplares similares
-
Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018) -
Mitochondrial DNA population variation is not associated with Alzheimer’s in the Japanese population: A consistent finding across global populations
por: Wong, Johanna, et al.
Publicado: (2022) -
Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
por: Esparza, Thomas J., et al.
Publicado: (2016) -
Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015) -
Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
por: Phan, Huong T. T., et al.
Publicado: (2019)